Q42703641 | 'New to me': changing patient understanding of psoriasis and identifying mechanisms of change. The Pso Well® patient materials mixed-methods feasibility study. |
Q51751983 | A community study of the presence of anxiety disorder in people with epilepsy. |
Q57239479 | A cross-sectional study of the prevalence of psychopathology in adults with congenital heart disease |
Q33934709 | A prospective study of the psychological impact on patients with a first episode of genital herpes |
Q73634547 | A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population |
Q24812242 | An investigation into the psychometric properties of the Hospital Anxiety and Depression Scale in patients with breast cancer |
Q41702054 | Anxiety and Depression in Adolescents With Epilepsy |
Q51133766 | Anxiety and depression in migraine. |
Q35484728 | Are investigations anxiolytic or anxiogenic? A randomised controlled trial of neuroimaging to provide reassurance in chronic daily headache |
Q40697948 | Assessing psychopathology in pregnancy and postpartum |
Q34216648 | Assessing the psychosocial consequences of epilepsy: a community-based study |
Q40414365 | Assessment of anxiety in hospital patients |
Q87418728 | Caregiver burden in end-of-life care: advanced cancer and final stage of dementia |
Q48915370 | Clinical and psychosocial factors associated with depression and anxiety in Singaporean patients with rheumatoid arthritis |
Q50600428 | Correlation and agreement of self-assessed and objective skin disease severity in a cross-sectional study of patients with acne, psoriasis, and atopic eczema. |
Q33346638 | Depression and anxiety in relation to catechol-O-methyltransferase Val158Met genotype in the general population: the Nord-Trøndelag Health Study (HUNT). |
Q52864199 | Evaluation of a self-help leaflet in treatment of social difficulties following facial disfigurement. |
Q34465555 | Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology |
Q48031567 | Examination of the construct validity of the Swedish version of Hospital Anxiety and Depression Scale in breast cancer patients |
Q37204735 | Factor structure of the Hospital Anxiety and Depression Scale in Japanese psychiatric outpatient and student populations |
Q34341639 | Family caregiver burden: results of a longitudinal study of breast cancer patients and their principal caregivers. |
Q35823607 | Follow up of patients presenting with fatigue to an infectious diseases clinic |
Q35059252 | Hand disease in scleroderma: a clinical correlate for chronic hand transplant rejection |
Q36849057 | International experiences with the Hospital Anxiety and Depression Scale--a review of validation data and clinical results |
Q73500105 | Is the ‘clinic-home blood pressure difference’ associated with psychological distress? A primary care-based study |
Q50924583 | Low blood pressure associated with low mood: a red herring? |
Q44519084 | Measuring psychiatric disorder in the community: a standardized assessment for use by lay interviewers |
Q33703154 | Measuring quality of life in patients with myocardial infarction or stroke: a feasibility study of four questionnaires in The Netherlands |
Q34222146 | Membership of the Royal College of General Practitioners and recognition of depression in primary care. |
Q51080846 | Patients' illness perceptions and coping as predictors of functional status in psoriasis: a 1-year follow-up. |
Q52034813 | Psychiatric morbidity in women attending a clinic for vulval problems--is there a higher rate in vulvodynia? |
Q61646612 | Psychological adjustment to systemic sclerosis—exploring the association of disease factors, functional ability, body related attitudes and fear of negative evaluation |
Q36090597 | Psychological symptoms associated with genital herpes virus infections: epidemiology and approaches to management. |
Q61835766 | Psychometric Properties of Parent Outcome Measures Used in RCTs of Antenatal and Early Years Parent Programs: A Systematic Review |
Q43429950 | Psychometric properties of the Hospital Anxiety and Depression Scale and The General Health Questionnaire-20 in COPD inpatients. |
Q77930887 | Quality of life assessment in the collaborative ocular melanoma study: design and methods. COMS-QOLS Report No. 1. COMS Quality of Life Study Group |
Q48865576 | Relationship between psychological status and disease activity and quality of life in ankylosing spondylitis. |
Q40670876 | Reliability testing of the hospital anxiety and depression (HAD) scale in the English, Maltese and back-translation versions |
Q47213078 | Retesting the validity of the Arabic version of the Hospital Anxiety and Depression (HAD) scale in primary health care |
Q48962770 | Risk factors associated with transfer anxiety among patients transferring from the intensive care unit to the ward |
Q44922603 | Screening for psychiatric morbidity in a medical outpatient clinic for HIV infection: the need for a psychiatric presence |
Q47580580 | The contribution of perceptions of stigmatisation to disability in patients with psoriasis |
Q63285325 | The impact of psychological and clinical factors on quality of life in individuals with atopic dermatitis |
Q51828938 | The presence and clinical implications of depression in a community population of adults with epilepsy. |
Q51090339 | The psychological and emotional impact of acne and the effect of treatment with isotretinoin. |
Q43124299 | The relationship between allergy and asthma control, quality of life, and emotional status in patients with asthma: a cross-sectional study |
Q34113060 | The validity of the Hospital Anxiety and Depression Scale. An updated literature review |
Q43812374 | Three-dimensional structure of the Hospital Anxiety and Depression Scale in a large French primary care population suffering from major depression |
Q51061669 | Use of a cross-sectional survey to estimate outcome of health care: the example of anxiety and depression. |
Q41261945 | Use of the Hospital Anxiety and Depression Scale in Spanish caregivers. |
Q38438485 | Validation of the generalized anxiety disorder-7 in people with epilepsy: a MEPSY study |
Search more.